RU2506947C2 - Таблетка пролонгированного высвобождения, содержащая теобромин - Google Patents

Таблетка пролонгированного высвобождения, содержащая теобромин Download PDF

Info

Publication number
RU2506947C2
RU2506947C2 RU2012119070/15A RU2012119070A RU2506947C2 RU 2506947 C2 RU2506947 C2 RU 2506947C2 RU 2012119070/15 A RU2012119070/15 A RU 2012119070/15A RU 2012119070 A RU2012119070 A RU 2012119070A RU 2506947 C2 RU2506947 C2 RU 2506947C2
Authority
RU
Russia
Prior art keywords
theobromine
release layer
sustained release
layer
release
Prior art date
Application number
RU2012119070/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2012119070A (ru
Inventor
Джин АУХ
Чан-Хван КИМ
Чан-Кюн ХАН
Хён-Гун ДЖОН
Ян-Джоон КИМ
Джон-Гиал КИМ
Джу-Ён ЁУН
Джун-Хва ЛЕЕ
Original Assignee
Ахн-Гоок Фармасьютикал Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ахн-Гоок Фармасьютикал Ко., Лтд. filed Critical Ахн-Гоок Фармасьютикал Ко., Лтд.
Publication of RU2012119070A publication Critical patent/RU2012119070A/ru
Application granted granted Critical
Publication of RU2506947C2 publication Critical patent/RU2506947C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2012119070/15A 2009-11-02 2010-09-01 Таблетка пролонгированного высвобождения, содержащая теобромин RU2506947C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2009-0105137 2009-11-02
KR1020090105137A KR101137467B1 (ko) 2009-11-02 2009-11-02 테오브로민 함유 서방성 정제
PCT/KR2010/005911 WO2011052884A2 (ko) 2009-11-02 2010-09-01 테오브로민 함유 서방성 정제

Publications (2)

Publication Number Publication Date
RU2012119070A RU2012119070A (ru) 2013-12-10
RU2506947C2 true RU2506947C2 (ru) 2014-02-20

Family

ID=43922740

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2012119070/15A RU2506947C2 (ru) 2009-11-02 2010-09-01 Таблетка пролонгированного высвобождения, содержащая теобромин

Country Status (7)

Country Link
KR (1) KR101137467B1 (tr)
CN (1) CN102711740B (tr)
BR (1) BR112012010325B8 (tr)
RU (1) RU2506947C2 (tr)
TR (1) TR201205029T1 (tr)
UA (1) UA103558C2 (tr)
WO (1) WO2011052884A2 (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101220830B1 (ko) * 2010-08-18 2013-01-10 안국약품 주식회사 테오브로민의 서방성 과립제 및 그 제조방법

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060113728A (ko) * 2003-11-13 2006-11-02 룀 게엠베하 조절 물질의 전달에 영향을 미치는 매트릭스를 갖는 다층약제학적 형태
KR20070017335A (ko) * 2004-03-22 2007-02-09 노파르티스 아게 리카르바제핀을 포함하는 경구투여용 매트릭스 제제
RU2292873C2 (ru) * 2002-07-25 2007-02-10 Фармация Корпорейшн Таблетка с замедленным высвобождением, содержащая ребоксетин
KR20070078625A (ko) * 2006-01-27 2007-08-01 씨제이 주식회사 멀티플 유닛 타입 서방성 경구 제제 및 그 제조방법
KR20070119658A (ko) * 2005-03-29 2007-12-20 에보니크 룀 게엠베하 활성 성분 방출에 대한 조절 효과를 가지는 물질을포함하는 펠렛을 포함하는 다중 미립자 제약 형태

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2292873C2 (ru) * 2002-07-25 2007-02-10 Фармация Корпорейшн Таблетка с замедленным высвобождением, содержащая ребоксетин
KR20060113728A (ko) * 2003-11-13 2006-11-02 룀 게엠베하 조절 물질의 전달에 영향을 미치는 매트릭스를 갖는 다층약제학적 형태
KR20070017335A (ko) * 2004-03-22 2007-02-09 노파르티스 아게 리카르바제핀을 포함하는 경구투여용 매트릭스 제제
KR20070119658A (ko) * 2005-03-29 2007-12-20 에보니크 룀 게엠베하 활성 성분 방출에 대한 조절 효과를 가지는 물질을포함하는 펠렛을 포함하는 다중 미립자 제약 형태
KR20070078625A (ko) * 2006-01-27 2007-08-01 씨제이 주식회사 멀티플 유닛 타입 서방성 경구 제제 및 그 제조방법

Also Published As

Publication number Publication date
KR20110048367A (ko) 2011-05-11
WO2011052884A2 (ko) 2011-05-05
CN102711740A (zh) 2012-10-03
RU2012119070A (ru) 2013-12-10
TR201205029T1 (tr) 2012-09-21
WO2011052884A3 (ko) 2011-07-14
BR112012010325A2 (pt) 2016-03-29
BR112012010325B8 (pt) 2021-05-25
UA103558C2 (ru) 2013-10-25
CN102711740B (zh) 2014-02-12
BR112012010325B1 (pt) 2021-01-26
KR101137467B1 (ko) 2012-04-20

Similar Documents

Publication Publication Date Title
US10463676B2 (en) Modified-release dosage forms of 5-HT2C agonists useful for weight management
KR100936572B1 (ko) 안정한 서방출형의 경구 투여용 조성물
KR100882707B1 (ko) 라모트리진을 포함하는 서방형 제제
CA2182004C (en) Film coated tablet of paracetamol and domperidone
WO2004054574A1 (ja) 経口固形医薬
CN111479559A (zh) 包含莫沙必利和雷贝拉唑的片包片复合制剂
WO2010128525A2 (en) A formulation of ivabradine for treating the cardiovascular disease
HUE028598T2 (en) Extended release nevirapine preparation
RU2006137330A (ru) Пероральные матричные композиции, содержащие ликарбазепин
KR20190000657A (ko) 분자량분포 특성을 조절한 모사프리드 함유 서방제제
KR20190000659A (ko) 신규한 용출 파라미터를 이용한 모사프리드 함유 서방제제
KR101414814B1 (ko) 염산레르카니디핀 및 발사르탄을 포함하는 복합 제제 및 이의 제조방법
KR20190000661A (ko) 1일 1회 경구투여하는 모사프리드 함유 서방제제
CN101972263B (zh) 一种缬沙坦氢氯噻嗪药物组合物脂质体固体制剂
RU2506947C2 (ru) Таблетка пролонгированного высвобождения, содержащая теобромин
AU2006301573B2 (en) Retard formulation for pralnacasan
AU2015268758B2 (en) Modified-release dosage forms of 5-HT2c agonists useful for weight management
CA2481377A1 (en) Antihistamine-decongestant pharmaceutical compositions
KR102294186B1 (ko) 1일 1회 경구투여하는 모사프리드 함유 서방제제
AU4688599A (en) Method of treatment
RU2668499C2 (ru) Фармацевтическая композиция в форме таблеток, покрытых кишечнорастворимой оболочкой, и способ ее получения
KR20220085746A (ko) 염산 클로미프라민의 제어 방출을 위한 이중정 및 이의 제조방법
CN102349904A (zh) 一种全新的口服固体药用组合物及其制备方法
RU2270010C2 (ru) Фармацевтическая композиция, обладающая снотворным действием
WO2018186866A1 (en) Sustained release compositions of 4-aminopyridine